If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Pre-close Trading Update

9 Feb 2017 07:00

RNS Number : 3902W
TyraTech, Inc.
09 February 2017
 

 

 

Strictly embargoed until: 9 February 2017

 

TyraTech, Inc.

("TyraTech" or the "Company")

 

Pre-Close Trading Update

 

TyraTech, Inc. (AIM: TYR, and TYRU), a life sciences company focused on nature-derived insect and parasite control products, announces its pre-close trading update ahead of its Preliminary Results for the year ended 31 December 2016.

 

Market Overview and Financial Update

 

Despite a difficult market environment, gross sales of the Company's market leading Vamousse® head lice range of products continued to show double digit growth year on year, and the Vamousse brand gained market share against its major competitors.

 

The Company had indicated at the time of its Interim Results in September 2016, that the overall rate of growth of Vamousse had slowed in the second half of the year, mainly due to a deceleration of the lice category in the US, but the market did recover somewhat at the end of the year and finished almost flat in the US for the full year 2016.

 

In order to adapt to these market conditions, the Company has strictly controlled its overall level of expenses, and still expects the year end results to be broadly in line with current market forecasts and its cash position to be in excess of $1.7 m.

 

Business Update

 

Individual retail outlets across the distribution network in the US are now adding new Vamousse product Stock Keeping Units (SKUs), which is being driven by consumer demand. The Company is pleased that following CVS in the US in 2016, Walgreens, the biggest pharmaceutical chain with over 8,000 stores has also decided to add Vamousse Lice Defense shampoo and Vamousse Lice Elimination powder to Vamousse Treatment for the 2017 season.

 

After only being available online Guardian® (TyraTech's plant-based, non-toxic mosquito and tick repellent), will now be tested in Kroger stores, the biggest grocery chain in the US for the 2017 season.

 

In other initiatives, the Company has successfully finalized the development of its innovative, effective and non-toxic OutSmart™ Fly Spray repellent for the equine market. An additional patent filing has been made for the new formulation which was pre-launched by TyraTech's partner SmartPak at the end of 2016. The full launch for this product is expected during the second quarter of 2017 before the fly season begins.

 

The three animal health products sold under the brand PureScience™ are showing positive field testing results. Products have already been purchased and have received good feedback from several production facilities affiliated with the major poultry and swine producers in the US. Widespread adoption will take time, but reports from our partner MWI, the biggest distributor of animal health products in the US, show that the products are performing well.

 

Outlook, Strategic Direction and Date of Final Results

 

Taking into account the market conditions and these new product placements and adoptions, the Board is currently more cautious about revenue expectations but still anticipates double digit revenue growth in 2017. In addition, the Board continues to consider the strategic direction of the Company with respect to the personal care range of products including the Vamousse brand and the ultimately larger animal health opportunities.

 

The Company will announce Final Results for the year ended 31 December 2016 by the end of April 2017.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information:

 

TyraTech Inc.

Bruno Jactel, Chief Executive Officer

Erica H. Boisvert, Chief Financial Officer

www.tyratech.com

 

Tel: +1 919 415 4340

Tel: +1 919 415 4287

 

SPARK Advisory Partners Limited (Nominated Adviser)

Matt Davis / Mark Brady

 

 

 Tel: +44 20 3368 3551

 

Allenby Capital Limited (Broker)

Chris Crawford

 

 

Tel: +44 20 3328 5656

 

 

Belvedere Communications (PR)

John West / Kim van Beeck

 Tel: +44 20 3567 0510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUWGPUPMGRR
Date   Source Headline
26th Sep 20087:00 amRNSInterim Results
22nd Sep 20087:00 amRNSTrading Update
15th Sep 200812:28 pmRNSNotice of Results
29th Aug 20083:48 pmRNSRestructuring Closed
28th Aug 20087:00 amRNSChange of Shareholding
18th Aug 20086:11 pmRNSSpecial Meeting Result
8th Aug 20087:00 amRNSCircular
4th Aug 20087:00 amRNSCirc re. XL TechGroup
30th Jun 20082:45 pmRNSAnnual Report and Accounts 20
27th Jun 20088:17 amRNSTemporary Suspension of Tradi
9th Jun 20085:07 pmRNSLoan Settlement
15th May 200812:30 pmRNSAGM Result
17th Apr 20087:01 amRNSEmployee Loan
7th Apr 20087:01 amRNSBoard Changes
2nd Apr 20087:01 amRNSTyraTech Final Results
2nd Apr 20087:01 amRNSPreliminary Results
17th Mar 20087:02 amRNSAppointment
27th Feb 20087:01 amRNSOperating update
10th Jan 20087:00 amRNSArysta Milestone Payments
10th Jan 20087:00 amRNSArysta milestone payment
17th Dec 20077:01 amRNSTyraTech Kraft payment
17th Dec 20077:01 amRNSKraft milestone payment
19th Nov 20077:05 amRNSTyraTech Sustainable Business
19th Nov 20077:01 amRNSSustainable Business Launch
16th Oct 20077:05 amRNSTyraTech product launch
16th Oct 20077:01 amRNSProduct launch & first order
4th Oct 20077:01 amRNSnew borrowing facility
2nd Oct 20077:01 amRNSDirector/PDMR Shareholding
26th Sep 20077:01 amRNSTyraTech Interim Results
26th Sep 20077:01 amRNSInterim Results
15th Aug 200710:15 amRNSCompliance of AiM Rule 26
9th Jul 20074:00 pmRNSVP appointment
1st Jun 20078:51 amRNSTyraTech 1st day of Dealings
1st Jun 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.